Today news
The same in other media
Johnson & Johnson cuts profit outlook for 2020
Reading now: 402
Johnson & Johnson is cutting its profit expectations for the year as the coronavirus disrupts economies worldwide. Medical procedures, hospital and doctor visits in particular have been upended by the outbreak and Johnson & Johnson is the first major U.S.
drug and medical supply company to post quarterly earnings. The New Brunswick, New Jersey, company reported a first-quarter profit of $5.8 billion, or $2.17 per share.
Adjusted per-share earnings were $2.30, far exceeding projections of $2.03 from Wall Street analysts, according to a survey by Zacks Investment Research.
Revenue was $20.69 billion, also beating expectations. Johnson & Johnson expects adjusted full-year earnings in the range of $7.50 to $7.90 per share.
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.
COVID-19
United States
|
Cases: 46 252 513
Deaths: 750 423
Recovered: 0
|
India
|
Cases: 34 321 025
Deaths: 459 652
Recovered: 0
|
Brazil
|
Cases: 21 835 785
Deaths: 608 235
Recovered: 0
|
United Kingdom
|
Cases: 9 215 683
Deaths: 141 607
Recovered: 0
|
Russia
|
Cases: 8 494 589
Deaths: 237 619
Recovered: 0
|